Teladoc Health, Inc.·4

May 21, 5:14 PM ET

Paulus Kenneth H 4

4 · Teladoc Health, Inc. · Filed May 21, 2026

Research Summary

AI-generated summary of this filing

Updated

Teladoc (TDOC) Director Kenneth H. Paulus Receives RSU Award

What Happened Kenneth H. Paulus, a director of Teladoc Health, was granted 30,441 restricted stock units (RSUs) on 2026-05-21. The grant was recorded as a derivative award (transaction code A) at $0.00 per share — RSUs are a contingent right to receive common shares in the future rather than an immediate cash purchase or sale.

Key Details

  • Transaction date: 2026-05-21; Transaction type: Award/Grant (A); reported acquisition of 30,441 RSUs at $0.00.
  • Reported immediate value: $0 cash paid at grant; fair value or grant-date accounting value not shown in the Form 4.
  • Shares owned after transaction: Not specified in this filing.
  • Vesting/delivery terms (from footnotes): each RSU converts to one share; RSUs vest in full on the earlier of (i) May 21, 2027 or (ii) the day before Teladoc’s 2027 annual meeting. Vested shares will be delivered upon the earliest of specified events (post-separation timing, a Change of Control, or the reporting person’s death).
  • Filing timeliness: Form 4 filed on 2026-05-21 (same day as the transaction), indicating timely reporting.

Context RSUs are a common form of director compensation and do not represent immediate ownership of common shares until they vest and are delivered. This grant is a non-cash compensation award rather than an open-market purchase or sale, so it should be viewed as routine director compensation rather than a direct trading signal.

Insider Transaction Report

Form 4
Period: 2026-05-21
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-05-21+30,44130,441 total
    Common Stock (30,441 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
  • [F2]The restricted stock units vest in full on the earlier of (i) May 21, 2027 and (ii) the day immediately preceding the issuer's 2027 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact|2026-05-21

Documents

1 file
  • 4
    wk-form4_1779398044.xmlPrimary

    FORM 4